Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage

Surgical Neurology

Volumn 71, Issue 3, 2009, Pages 311-317

  Moskowitz, Shaye I ^a   Ahrens, Christine ^a   Provencio, J Javier ^a   Chow, Michael ^b   Rasmussen, Peter A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aneurysm; Delayed cerebral ischemia; HMG CoA reductase inhibitor; Statin; Vasospasm

Indexed keywords

ATORVASTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN VASOSPASM; DRUG MECHANISM; DRUG USE; DRUG WITHDRAWAL; ENDOVASCULAR SURGERY; HUMAN; PREHEMORRHAGE DRUG USE; RISK REDUCTION; SCORING SYSTEM; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 60649114882     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.12.027     Document Type: Article

References (26)

1. Amin-Hanjani S., Stagliano N.E., Yamada M., Huang P.L., Liao J.K., and Moskowitz M.A. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32 4 (2001) 980-986
2. Endres M., Laufs U., Huang Z., Nakamura T., Huang P., Moskowitz M.A., and Liao J.K. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 95 15 (1998) 8880-8885
3. Gabikian P., Clatterbuck R.E., Eberhart C.G., Tyler B.M., Tierney T.S., and Tamargo R.J. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke 33 11 (2002) 2681-2686
4. Goksel H.M., Karadag O., Turaclar U., Tas F., and Oztoprak I. Nitric oxide synthase inhibition attenuates vasoactive response to spinal cord stimulation in an experimental cerebral vasospasm model. Acta Neurochirurg 143 4 (2001) 383-390
5. Haendler J., Hoffman J., Zeiher A.M., and Dimmler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells. Circulation 110 (2004) 856-861
6. Harrod C.G., Bendok B.R., and Batjer H.H. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 56 4 (2005) 633-654
7. Hernandez-Perera O., Perez-Sala D., Navarro-Antolin J., Sanchez-Pascuala R., Hernandez G., Diaz C., and Lamas S. Effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101 12 (1998) 2711-2719
8. Hoh B.L., Topcuoglu M.A., Singhal A.B., Pryor J.C., Rabinov J.D., Rordorf G.A., Carter B.S., and Ogilvy C.S. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 55 4 (2004) 779-786
9. Jung K.H., Chu K., Jeong S.W., Han S.Y., Lee S.T., Kim J.Y., Kim M., and Roh J.K. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35 7 (2004) 1744-1749
10. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 12 (1998) 1129-1135
11. Lynch J.R., Wang H., McGirt M.J., Floyd J., Friedman A.H., Coon A.L., Blessing R., Alexander M.J., Graffagnino C., Warner D.S., and Laskowitz D.T. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36 (2005) 2024-2026
12. McGirt M.J., Blessing R., Alexander M.J., Nimjee S.M., Woodworth G.F., Friedman A.H., Graffagnino C., Laskowitz D.T., and Lynch J.R. Risk of cerebral vasospasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience. J Neurosurg 105 5 (2006) 671-674
13. McGirt M.J., Lynch J.R., Parra A., Sheng H., Pearlstein R.D., Laskowitz D.T., Pelligrino D.A., and Warner D.S. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33 12 (2002) 2950-2956
14. Paiva H., Laasko J., Lehtimaki T., Isomustajarvi M., Ruokonen I., and Laaksonen R. Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors. J Cardiovasc Pharmacol 41 2 (2003) 219-222
15. Parra A., Kreiter K.T., Williams S., Sciacca R., Mack W.J., Naidech A.M., Commichau C.S., Fitzsimmons B.F., Janjua N., Mayer S.A., and Connolly Jr. E.S. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56 3 (2005) 476-484
16. Pathak A., Mathuriya S.N., Khandelwal N., and Verma K. Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm. Br J Neurosurg 17 4 (2003) 306-310
17. Pluta R.M. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Therapeut 105 (2005) 23-56
18. Pradilla G., Legnani ThaiF., Hsu W., Kretzer R., Wang P.P., and Tamargo R.J. Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 55 6 (2004) 1393-1400
19. Rabinstein A.A., Pichelmann M.A., Friedman J.A., Piepgras D.G., Nichols D.A., McIver J.I., Toussaint III L.G., McClelland R.L., Fulgham J.R., Meyer F.B., Atkinson J.L., and Wijdicks E.F. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 98 2 (2003) 319-325
20. Shishehbor M.H., Brennan M., Aviles R.J., Fu X., Penn M.S., Sprecher D.L., and Hazn S.L. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108 (2003) 426-431
21. Singhal A.B., Topcuoglu M.A., Dorer D.J., Ogilvy C.S., Carter B.S., and Koroshetz W.J. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64 (2005) 1008-1013
22. Solenski N.J., Haley Jr. E.C., Kassell N.F., Kongable G., Germanson T., Truskowski L., and Torner J.C. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter cooperative aneurysm study. Crit Care Med 23 (1995) 1007-1017
23. Thomas J.E., and McGinnis G. Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke 33 (2002) 486-492
24. Thomas J.E., and Rosenwasser R.H. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 44 1 (1999) 48-57
25. Tseng M.Y., Czosnyka M., Richards H., Pickard J.D., and Kirkpatrick P.J. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneursmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36 (2005) 1627-1632
26. Wolfrum S., Grimm M., Heidbreder M., Dendorfer A., Katus H.A., Liao J.K., and Richardt G. Acute reduction of myocardial infarct size by hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol 41 3 (2003) 474-478